ModelEdge
Accentia Biopharmaceuticals Inc
0001310094
Filing type
10-K
Filing date
Dec 18, 2011
Updated
Dec 19, 2011 ยท 10:15 AM

Filing

10-KFORM 10-K

Exhibits

EX-10.57ROYALTY TERMINATION AGREEMENTEX-10.58CLASS 4 PLAN PROMISSORY NOTEEX-10.59STOCK PLEDGE AGREEMENTEX-10.60ASSET PURCHASE AGREEMENTEX-10.61AGREEMENTEX-10.62LOAN SECURITY TERMINATION AGREEMENTEX-10.63LOAN PREPAYMENT, MODIFICATION AND SECURITY TERMINATION AGREEMENTEX-10.64AMENDED AND RESTATED SECURED TERM NOTEEX-10.65AMENDED AND RESTATED SECURED TERM NOTEEX-10.66AMENDED AND RESTATED SECURED TERM NOTEEX-10.67AMENDED AND RESTATED SECURED TERM NOTEEX-21SUBSIDIARIES OF ACCENTIAEX-31.1CERTIFICATIONEX-31.2CERTIFICATIONEX-32.1CERTIFICATIONEX-32.2CERTIFICATIONEX-101.INSXBRL INSTANCE DOCUMENTGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicGRAPHICGraphicEXCELIDEA: XBRL DOCUMENT